Jove
Visualize
Contact Us

Related Concept Videos

Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From the Heart: Eugene Braunwald (1929-2026).

JAMA cardiology·2026
Same author

Endurance exercise remodels pulmonary vein sleeve myocytes and promotes a proarrhythmic atrial substrate.

European heart journal·2026
Same author

Weight Loss in Older Patients With Persistent Atrial Fibrillation: The LOSE-AF Randomized Clinical Trial.

JAMA·2026
Same author

Limited Visibility and Perception of the Clinical Relevance of Clopidogrel Pharmacogenetics in Cardiology Literature.

Clinical and translational science·2026
Same author

Interpreting AI-Enhanced ECG Performance in High-Risk, Resource-Limited Settings.

JAMA cardiology·2026
Same author

Severe Aortic Stenosis Is Associated With Left Atrial Prothrombotic Flow That Persists Despite Valve Replacement.

Journal of the American Heart Association·2026
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 10, 2026

Analysis of Tubular Membrane Networks in Cardiac Myocytes from Atria and Ventricles
10:30

Analysis of Tubular Membrane Networks in Cardiac Myocytes from Atria and Ventricles

Published on: October 15, 2014

Does nitric oxide modulate cardiac ryanodine receptor function? Implications for excitation-contraction coupling.

Gregory Lim1, Luigi Venetucci, David A Eisner

  • 1Department of Cardiovascular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, OX3 9DU, UK.

Cardiovascular Research
|November 17, 2007
PubMed
Summary

Nitric oxide (NO) signaling modulates cardiac function by affecting the ryanodine receptor Ca2+ release channel (RyR2). NO may directly impact RyR2, influencing calcium handling and contractility in cardiomyocytes.

More Related Videos

Assessment of Myofilament Ca2+ Sensitivity Underlying Cardiac Excitation-contraction Coupling
08:29

Assessment of Myofilament Ca2+ Sensitivity Underlying Cardiac Excitation-contraction Coupling

Published on: August 1, 2016

Related Experiment Videos

Last Updated: Jul 10, 2026

Analysis of Tubular Membrane Networks in Cardiac Myocytes from Atria and Ventricles
10:30

Analysis of Tubular Membrane Networks in Cardiac Myocytes from Atria and Ventricles

Published on: October 15, 2014

Assessment of Myofilament Ca2+ Sensitivity Underlying Cardiac Excitation-contraction Coupling
08:29

Assessment of Myofilament Ca2+ Sensitivity Underlying Cardiac Excitation-contraction Coupling

Published on: August 1, 2016

Area of Science:

  • Cardiovascular Physiology
  • Molecular Cardiology
  • Cellular Signaling

Background:

  • Nitric oxide (NO) is a key signaling molecule in cardiomyocytes, produced by endothelial (eNOS) and neuronal (nNOS) nitric oxide synthase.
  • NO is implicated in regulating excitation-contraction coupling (ECC), a process vital for heart function.
  • The ryanodine receptor Ca2+ release channel (RyR2) on the sarcoplasmic reticulum (SR) is a critical component of ECC.

Purpose of the Study:

  • To review evidence suggesting NO modulates RyR2 function in cardiomyocytes.
  • To explore the mechanisms by which NO might affect RyR2 activity.
  • To consider the implications of NO-RyR2 interactions in heart failure.

Main Methods:

  • Co-immunoprecipitation studies showing NOS isoforms interacting with RyR2.
  • Studies using eNOS gene deletion to assess NO's role in stretch-induced Ca2+ sparks.
  • Single-channel recordings of RyR2 reconstituted in lipid bilayers exposed to NO donors.

Main Results:

  • Both eNOS and nNOS co-immunoprecipitate with RyR2, indicating RyR2 as a potential NO target.
  • eNOS deletion abolished increased spontaneous Ca2+ spark frequency under stretch.
  • In vitro, NO dose-dependently increased RyR2 channel open probability (P(open)).

Conclusions:

  • NO, potentially via S-nitrosylation or downstream signaling, modulates RyR2 activity.
  • Altered NO signaling and RyR2 interaction in heart failure may contribute to impaired contractility.
  • Further investigation is needed into nNOS-derived NO effects and NO's role in heart failure pathophysiology.